Fieldpoint Private Securities’s Pfizer PFE Stock Holding History

Fieldpoint Private Securities’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.28M	Sell	24,459 -340	-1%	-$17.3K	0.37%	66
2022 Q1	$1.28M	Sell	24,799 -406	-2%	-$21.1K	0.26%	91
2021 Q4	$1.49M	Buy	25,205 +1,013	+4%	+$50.2K	0.29%	84
2021 Q3	$1.04M	Buy	24,192 +1,400	+6%	+$62K	0.23%	110
2021 Q2	$1.1M	Buy	22,792 +1,332	+6%	+$51.8K	0.24%	106
2021 Q1	$777K	Sell	21,460 -3,024	-12%	-$107K	0.18%	141
2020 Q4	$901K	Buy	24,484 +2,961	+14%	+$109K	0.2%	123
2020 Q3	$749K	Buy	21,523 +1,181	+6%	+$41.4K	0.22%	125
2020 Q2	$631K	Buy	20,342 +2,398	+13%	+$81.5K	0.21%	125
2020 Q1	$556K	Buy	17,944 +720	+4%	+$24.5K	0.21%	124
2019 Q4	$640K	Buy	17,224 +309	+2%	+$11K	0.19%	135
2019 Q3	$577K	Sell	16,915 -166	-1%	-$6.04K	0.21%	126
2019 Q2	$702K	Sell	17,081 -2,148	-11%	-$85.3K	0.22%	126
2019 Q1	$775K	Hold	19,229	–	–	0.32%	102
2018 Q4	$796K	Buy	19,229 +512	+3%	+$21.3K	0.35%	89
2018 Q3	$783K	Hold	18,717	–	–	0.3%	102
2018 Q2	$644K	Sell	18,717 -501	-3%	-$17.1K	0.25%	109
2018 Q1	$647K	Sell	19,218 -87	-0.5%	-$2.99K	0.3%	91
2017 Q4	$663K	Sell	19,305 -4,883	-20%	-$167K	0.35%	74
2017 Q3	$819K	Buy	24,188 +5,160	+27%	+$166K	0.35%	77
2017 Q2	$606K	Hold	19,028	–	–	0.41%	45
2017 Q1	$618K	Buy	+19,028	New	+$600K	0.48%	58

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fieldpoint Private Securities's PFE Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Pfizer (PFE) stake by 1.4% in Q2 2022, selling an estimated $17.3K and leaving 24,459 shares worth $1.28M. The position accounts for 0.37% of the portfolio, ranked #66.

Fieldpoint Private Securities first reported a position in PFE in Q1 2017 and has held it in 22 quarters since. The position peaked at $1.49M in Q4 2021. 3,158 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

Fieldpoint Private Securities held 24,459 shares of Pfizer worth $1.28M as of Q2 2022.
Fieldpoint Private Securities sold 340 Pfizer shares in Q2 2022, an estimated $17.3K.
Pfizer made up 0.37% of Fieldpoint Private Securities's portfolio in Q2 2022, its #66 holding.
Fieldpoint Private Securities first reported a position in Pfizer in Q1 2017 and has held it in 22 quarters since.
Fieldpoint Private Securities's Pfizer position peaked at $1.49M in Q4 2021.
3,158 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.